Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin (Q84098478)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 May 2011

Language	Label	Description	Also known as
English	Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin	scientific article published on 01 May 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin: a double-blind, placebo-controlled, 3-arm study (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Dose-dependent effects of omega-3-polyunsaturated fatty acids on systolic left ventricular function, endothelial function, and markers of inflammation in chronic heart failure of nonischemic origin (English)

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

1 reference

based on heuristic

inferred from title

chronic heart failure

1 reference

based on heuristic

inferred from title

author name string

Deddo Moertl

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Alexandra Hammer

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sabine Steiner

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Raisa Hutuleac

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Karin Vonbank

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Rudolf Berger

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

language of work or name

0 references

publication date

1 May 2011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

May 2011

1 reference

National Center for Biotechnology Information

PubMed publication ID

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21570522

2 December 2024

full work available at URL

https://api.elsevier.com/content/article/PII:S0002870311001645?httpAccept=text/xml

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

https://api.elsevier.com/content/article/PII:S0002870311001645?httpAccept=text/plain

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

American Heart Journal

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

161

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

915.e1-9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Tumor Necrosis Factor Soluble Receptors in Patients With Various Degrees of Congestive Heart Failure

1

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Inflammatory mediators and the failing heart: past, present, and the foreseeable future

2

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Relation of left ventricular ejection fraction and functional capacity with metabolism and inflammation in chronic heart failure with reduced ejection fraction (from the MIMICA Study).

3

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST).

4

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial

5

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Polyunsaturated fatty acids and inflammatory processes: New twists in an old tale

6

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

A randomised interventional trial of omega-3-polyunsaturated fatty acids on endothelial function and disease activity in systemic lupus erythematosus

7

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Fish oil, but not flaxseed oil, decreases inflammation and prevents pressure overload-induced cardiac dysfunction

8

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

9

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Statement on cardiopulmonary exercise testing in chronic heart failure due to left ventricular dysfunction: recommendations for performance and interpretation Part III: Interpretation of cardiopulmonary exercise testing in chronic heart failure and

10

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effects of the angiotensin converting enzyme inhibitor enalapril on the long-term progression of left ventricular dysfunction in patients with heart failure. SOLVD Investigators

11

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group

12

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Severity of left ventricular remodeling defines outcomes and response to therapy in heart failure: Valsartan heart failure trial (Val-HeFT) echocardiographic data

13

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Left ventricular reverse remodeling but not clinical improvement predicts long-term survival after cardiac resynchronization therapy.

14

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE).

15

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Progression of left ventricular dysfunction secondary to coronary artery disease, sustained neurohormonal activation and effects of ibopamine therapy during long-term therapy with angiotensin-converting enzyme inhibitor

16

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Quantitative evaluation of drug or device effects on ventricular remodeling as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction: a meta-analytic approach

17

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effects of n-3 polyunsaturated fatty acids and of rosuvastatin on left ventricular function in chronic heart failure: a substudy of GISSI-HF trial

18

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Negative inotropic effects of cytokines on the heart mediated by nitric oxide

19

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Anti-tumor necrosis factor-alpha antibody limits heart failure in a transgenic model

20

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Close relation of endothelial function in the human coronary and peripheral circulations

21

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Cardiac membrane fatty acid composition modulates myocardial oxygen consumption and postischemic recovery of contractile function.

22

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

(n-3) Long chain PUFA dose-dependently increase oxygen utilization efficiency and inhibit arrhythmias after saturated fat feeding in rats

23

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

PUFA and aging modulate cardiac mitochondrial membrane lipid composition and Ca2+ activation of PDH

24

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy

25

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

CXC-chemokines, a new group of cytokines in congestive heart failure--possible role of platelets and monocytes

26

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Targeted anticytokine therapy in patients with chronic heart failure: results of the Randomized Etanercept Worldwide Evaluation (RENEWAL).

27

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Complement activation and inhibition in myocardial ischemia and reperfusion injury

28

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effects of n-3 polyunsaturated fatty acid therapy on plasma inflammatory markers and N-terminal pro-brain natriuretic peptide in elderly patients with chronic heart failure

29

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Beneficial effects of pentoxifylline in patients with idiopathic dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitors and carvedilol: results of a randomized study

30

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effect of high- versus low-dose angiotensin converting enzyme inhibition on cytokine levels in chronic heart failure

31

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Immunomodulating therapy with intravenous immunoglobulin in patients with chronic heart failure

32

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Effect of thalidomide on cardiac remodeling in chronic heart failure: results of a double-blind, placebo-controlled study

33

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Dietary supplementation with marine omega-3 fatty acids improve systemic large artery endothelial function in subjects with hypercholesterolemia

34

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Fish oil improves arterial compliance in non-insulin-dependent diabetes mellitus

35

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Mechanisms of action of dietary fatty acids in regulating the activation of vascular endothelial cells during atherogenesis

36

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Pulmonary and peripheral vascular factors are important determinants of peak exercise oxygen uptake in patients with heart failure.

37

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Exercise intolerance in patients with chronic heart failure: role of impaired nutritive flow to skeletal muscle.

38

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Tumour necrosis factor alpha as a predictor of impaired peak leg blood flow in patients with chronic heart failure

39

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Dietary supplementation with marine fish oil improves in vitro small artery endothelial function in hypercholesterolemic patients: a double-blind placebo-controlled study

40

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

The ability of fish oil to suppress tumor necrosis factor alpha production by peripheral blood mononuclear cells in healthy men is associated with polymorphisms in genes that influence tumor necrosis factor alpha production

41

1 reference

10.1016/J.AHJ.2011.02.011

https://api.crossref.org/works/10.1016/J.AHJ.2011.02.011

2 December 2024

Identifiers

10.1016/J.AHJ.2011.02.011

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21570522%20AND%20SRC:MED&resulttype=core&format=json

1 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q84098478&oldid=2282498551"